0001123292-16-002943.txt : 20161103 0001123292-16-002943.hdr.sgml : 20161103 20161103161304 ACCESSION NUMBER: 0001123292-16-002943 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151123 FILED AS OF DATE: 20161103 DATE AS OF CHANGE: 20161103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisman Wayne CENTRAL INDEX KEY: 0001602327 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 161971730 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4/A 1 edgar.xml PRIMARY DOCUMENT X0306 4/A 2015-11-23 2016-05-23 0001588972 Recro Pharma, Inc. REPH 0001602327 Weisman Wayne 490 LAPP ROAD MALVERN PA 19355 1 0 0 0 Common Stock 0 D On May 23, 2016, the reporting person filed a Form 4 mistakenly reporting indirect beneficial ownership for shares of common stock owned by SCP Vitalife Partners (Israel) II, L.P. and SCP Vitalife Partners II L.P and sold in fourteen transactions occurring between November 23, 2015 through May 20, 2016, which consisted of the sale of an aggregate of 58,331 shares of common stock. During the period from November 23, 2015 through May 20, 2016, the reporting person did not have indirect beneficial ownership of such shares. /s/ Donna Nichols, attorney-in-fact 2016-11-03